Abstract

BackgroundIt is still challenging to detect endolymphatic hydrops (EH) in patients with Meniere’s disease (MD) using MRI. The aim of the present study was to optimize a sensitive technique generating strong contrast enhancement from minimum gadolinium–diethylenetriamine pentaacetic acid (Gd–DTPA) while reliably detecting EH in the inner ear, including the apex.Materials and methodsAll imaging was performed using a 3.0 T MR system 24 h after intratympanic injection of low-dose Gd–DTPA. Heavily T2-weighted 3-dimensional fluid-attenuated inversion recovery reconstructed with magnitude and zero-filled interpolation (hT2W–FLAIR–ZFI) was optimized and validated in phantom studies and compared with medium inversion time inversion recovery imaging with magnitude reconstruction (MIIRMR). The following parameters were used in hT2W–FLAIR–ZFI: repetition time 14,000 ms, echo time 663 ms, inversion time 2900 ms, flip angle 120°, echo train length 271, and field of view 166 × 196 mm2.ResultsMRI obtained using hT2W–FLAIR–MZFI yielded high-quality images with sharper and smoother borders between the endolymph and perilymph and a higher signal intensity ratio and more homogenous perilymph enhancement than those generated with MIIRMR (p < 0.01). There were predominantly grade II EHs in the cochleae and grade III EHs in the vestibule in definite MD. EH was detected in the apex of 11/16 ipsilateral ears, 3/16 contralateral ears in unilateral definite MD and 3/6 ears in bilateral MD.ConclusionsThe novel hT2W–FLAIR–MZFI technique is sensitive and demonstrates strong and homogenous enhancement by minimum Gd–DTPA in the inner ear, including the apex, and yields high-quality images with sharp borders between the endolymph and perilymph.

Highlights

  • MRI has been increasingly used to assess endolymphatic hydrops (EH) in clinical practice to diagnose inner ear diseases, especially Meniere’s disease (MD), since the first report of an animal study in 2000 and following optimization of the MRI protocol [1,2,3,4,5,6]

  • Strong contrast enhancement of the perilymph is essential for reporting reliable results of EH, which depends on sufficient distribution of the contrast agents in the inner ear and the MRI sequence

  • The curve created with h­ T2W–FLAIR–MZFI had a larger intercept and smaller slope than that created with MIIRMR (y = 1.44 + 0.36 x and y = 1.34 + 0.57 x, respectively) (Fig. 1)

Read more

Summary

Introduction

MRI has been increasingly used to assess endolymphatic hydrops (EH) in clinical practice to diagnose inner ear diseases, especially Meniere’s disease (MD), since the first report of an animal study in 2000 and following optimization of the MRI protocol [1,2,3,4,5,6]. Strong contrast enhancement of the perilymph is essential for reporting reliable results of EH, which depends on sufficient distribution of the contrast agents (gadolinium chelate) in the inner ear and the MRI sequence. This is not guaranteed with the current technique. The aim of the present study was to optimize a sensitive technique generating strong contrast enhancement from minimum gadolinium–diethylenetriamine pentaacetic acid (Gd–DTPA) while reliably detecting EH in the inner ear, including the apex. Conclusions The novel ­hT2W–FLAIR–MZFI technique is sensitive and demonstrates strong and homogenous enhancement by minimum Gd–DTPA in the inner ear, including the apex, and yields high-quality images with sharp borders between the endolymph and perilymph

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call